Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7419 p360
23 September 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


GP prescribing of statins reduced after over-the-counter availability

Geoff Kidd/Science Photo Library

Statin

Statin availability over the counter coincided with a fall in prescriptions

Statin prescribing by GPs has fallen in the UK since simvastatin 10mg became available over the counter, a recent study published online reveals.

Investigators examined all statin prescriptions in the General Practice Research Database from the first quarter of 2001 to the second quarter of 2005, and found that during the four quarters after the introduction of OTC simvastatin in 2004 there was a decrease of 281 prescriptions per 100,000 people per quarter (P<0.0001). The decrease was not restricted to prescriptions for 10mg of statin — it was also seen for all statin prescriptions for 20mg or over. The authors say that the data suggest a significant impact of OTC statin availability on GPs’ prescribing of the agents, and that the policy could be leading to less aggressive statin therapy.

However, for reasons unknown to the authors, a similar trend of falling prescriptions was also observed for several other cardiovascular medicines — a trend not seen for non-cardiovascular drugs. They therefore concede that the reduction in statin prescriptions could be influenced by the same, unknown factors that are driving the decrease in overall prescribing of cardiovascular drugs (Pharmacoepidemiology and Drug Safety, 5 September 2006).

Back to Top


©The Pharmaceutical Journal